News

The Nagpur facility is intended to export formulations to developed markets like US, Europe, Japan and along with other key emerging markets. The new formulation plant is expected

LE-Poly ICLC is an antiviral agent proven to be effective in animal studies against avian influenza virus, ebola and alphavirus infections. Under a sub-contract from Oncovir, Dalton established

The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development. The dashboard utilizes content from Thomson Reuters

Under the agreement, ProMetic will receive $1.4m and the client will be provided with a biosimilar product. PBL chief executive officer Steve Burton said the company’s technology allows

The production process is an environmentally friendly and indicates the potential for improving the overall increase in yield of sitagliptin, while decreasing waste byproducts, Codexis said. Codexis interim

The products include JHP-Rodler, Betadorm D, Rhinopront, Collomack Topical, Tirgon and Xitix. Recordati chairman and CEO Giovanni Recordati said, "The OTC pharmaceutical segment in Germany is worth around

The company begins the shipment of the product, which is the generic equivalent to Eli Lilly and Company’s Zyprexa. The product is indicated for the treatment of schizophrenia

Under the agreement, Astellas will transfer all rights and assets related to ASP3291, whose Phase IIa study is currently being initiated, to Telsar, a virtual company that will

The study has demonstrated the bioavailability enhancing properties of silica in humans, which enables active pharmaceutical ingredients to effectively absorb into the body. Grace New Business Development vice